La Rosée, P., Müller, M. C., Erben, P., & Saußele, S. (2013). Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib. Annals of hematology, 92(10), .
Chicago Style (17th ed.) CitationLa Rosée, Paul, Martin Christian Müller, Philipp Erben, and Susanne Saußele. "Improved Tolerability by a Modified Intermittent Treatment Schedule of Dasatinib for Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Imatinib." Annals of Hematology 92, no. 10 (2013).
MLA (9th ed.) CitationLa Rosée, Paul, et al. "Improved Tolerability by a Modified Intermittent Treatment Schedule of Dasatinib for Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Imatinib." Annals of Hematology, vol. 92, no. 10, 2013.